ROMENVI Trademark

Trademark Overview


On Wednesday, February 2, 2022, a trademark application was filed for ROMENVI with the United States Patent and Trademark Office. The USPTO has given the ROMENVI trademark a serial number of 97251122. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 15, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The ROMENVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines
romenvi

General Information


Serial Number97251122
Word MarkROMENVI
Filing DateWednesday, February 2, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Wednesday, August 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, February 5, 2022NEW APPLICATION ENTERED
Tuesday, February 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, November 15, 2022ASSIGNED TO EXAMINER
Wednesday, November 16, 2022SUSPENSION LETTER WRITTEN
Wednesday, November 16, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, November 16, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, May 30, 2023SUSPENSION INQUIRY WRITTEN
Friday, January 19, 2024ASSIGNED TO LIE
Tuesday, May 30, 2023INQUIRY TO SUSPENSION E-MAILED
Tuesday, May 30, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, August 30, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 22, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 16, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 15, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, February 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER